5IOP
Cetuximab Fab in complex with 4-bromophenylalanine meditope variant
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 7 |
Details | binding site for residue PO4 A 301 |
Chain | Residue |
A | ARG39 |
A | ARG45 |
A | PRO59 |
A | ARG61 |
A | GLU81 |
A | HOH406 |
A | HOH408 |
site_id | AC2 |
Number of Residues | 9 |
Details | binding site for residue PO4 B 301 |
Chain | Residue |
B | VAL169 |
B | HIS170 |
B | HOH406 |
B | HOH412 |
B | HOH418 |
B | HOH420 |
B | HOH444 |
A | GLU165 |
A | ASP167 |
site_id | AC3 |
Number of Residues | 6 |
Details | binding site for residue PO4 C 301 |
Chain | Residue |
C | GLU165 |
C | ASP167 |
C | HOH425 |
C | HOH445 |
D | VAL169 |
D | HIS170 |
Functional Information from PROSITE/UniProt
site_id | PS00290 |
Number of Residues | 7 |
Details | IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YACEVTH |
Chain | Residue | Details |
A | TYR192-HIS198 | |
B | TYR200-HIS206 |